After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Agios Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Agios Pharmaceuticals Inc is $2.27B. A total of 0.7 million shares were traded on the day, compared to an average of 579.15K shares.
In the most recent transaction, Gheuens Sarah sold 11,914 shares of AGIO for 37.99 per share on Jul 09 ’25. After the transaction, the Chief Medical Officer now owns 61,271 company shares. In a previous transaction on Jul 10 ’25, DAVID SCADDEN bought 1,400 shares at 40.00 per share.
Among the insiders who bought shares, SARAH GHEUENS acquired of 11,914 shares on Jul 09 ’25 at a per-share price of $37.99. In another insider transaction, Gheuens Sarah sold 4,091 shares at $34.17 per share on Jul 01 ’25. Company shares held by the Chief Medical Officer now total 61,271.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $23.42.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $25.33, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.
